Search Results - Isabelle Desombere

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of... by Milena Callies, Ines Kabouche, Isabelle Desombere, Joanna Merckx, Mathieu Roelants, Melissa Vermeulen, Els Duysburgh

    Published in BMC Public Health (2023-05-01)
    Get full text
    Article


  2. 2

    Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022 by Johan Van der Heyden, Victoria Leclercq, Els Duysburgh, Laura Cornelissen, Isabelle Desombere, Inge Roukaerts, Lydia Gisle

    Published in Archives of Public Health (2024-05-01)
    Get full text
    Article


  3. 3

    Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study by Victoria Leclercq, Nayema Van den Houte, Lydia Gisle, Inge Roukaerts, Cyril Barbezange, Isabelle Desombere, Els Duysburgh, Johan Van der Heyden

    Published in Viruses (2022-04-01)
    Get full text
    Article


  4. 4

    Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study by Bea Vuylsteke, Natalie Fischer, Kristien Verdonck, Isabelle Thomas, Els Duysburgh, Laure Mortgat, Veronik Hutse, Cyril Barbezange, Leo Heyndrickx, Ines Kabouche, Kevin K Ariën, Isabelle Desombere

    Published in BMJ Open (2021-06-01)
    Get full text
    Article


  5. 5

    Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients by Frédéric Baron, Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, Kevin K. Ariën, Delphine Kemlin, Isabelle Desombere, Margaux Gerbaux, Margaux Gerbaux, Pieter Pannus, Yves Beguin, Yves Beguin, Arnaud Marchant, Stéphanie Humblet-Baron

    Published in Frontiers in Immunology (2022-03-01)
    Get full text
    Article


  6. 6

    Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant by Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, Betty Willems, Pieter Pannus, Geert A. Martens, Marjan Van Esbroeck, Maria E. Goossens, Arnaud Marchant, Koen Bartholomeeusen, Isabelle Desombere

    Published in npj Vaccines (2022-03-01)
    Get full text
    Article


  7. 7

    Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients by Lise Boey, Eline Bosmans, Liane Braz Ferreira, Nathalie Heyvaert, Melissa Nelen, Lisa Smans, Hanne Tuerlinckx, Mathieu Roelants, Kathleen Claes, Inge Derdelinckx, Wim Janssens, Chantal Mathieu, Johan Van Cleemput, Robin Vos, Isabelle Desombere, Corinne Vandermeulen

    Published in Vaccines (2021-01-01)
    Get full text
    Article


  8. 8

    Validation of a rapid SARS-CoV-2 antibody test in general practice by Herman Goossens, Ann Van den Bruel, Beatrice Scholtes, An De Sutter, Jan Yvan Jos Verbakel, Laetitia Buret, Pierre Van Damme, Samuel Coenen, Robin Bruyndonckx, Els Duysburgh, Stefan Heytens, Niels Adriaenssens, Isabelle Desombere, Julie Domen, Bart Peeters

    Published in BMJ Open (2023-05-01)
    Get full text
    Article


  9. 9

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K Ariën, Maria E Goossens

    Published in PLOS Global Public Health (2022-01-01)
    Get full text
    Article


  10. 10

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K. Ariën, Maria E. Goossens

    Published in PLOS Global Public Health (2022-01-01)
    Get full text
    Article


  11. 11

    Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients by Nicolas Gemander, Delphine Kemlin, Stéphanie Depickère, Natasha S. Kelkar, Pieter Pannus, Shilpee Sharma, Alexandra Waegemans, Véronique Olislagers, Daphnée Georges, Emilie Dhondt, Margarida Braga, Leo Heyndrickx, Johan Michiels, Anaïs Thiriard, Anne Lemy, Marylène Vandevenne, Maria E. Goossens, André Matagne, Isabelle Desombere, Kevin K. Ariën, Margaret E. Ackerman, Alain Le Moine, Arnaud Marchant

    Published in Kidney International Reports (2024-03-01)
    Get full text
    Article


  12. 12

    Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients by Nicolas Gemander, Julika Neumann, Rafael Veiga, Isabelle Etienne, Teresa Prezzemolo, Delphine Kemlin, Pieter Pannus, Stéphanie Depickère, Véronique Olislagers, Inès Vu Duc, Alexandra Waegemans, Margaux Gerbaux, Leoni Bücken, Hafid Dahma, Charlotte Martin, Nicolas Dauby, Maria E. Goossens, Isabelle Desombere, Carlos P. Roca, Mathijs Willemsen, Stanislas Goriely, Alain Le Moine, Arnaud Marchant, Adrian Liston, Stephanie Humblet-Baron

    Published in npj Vaccines (2025-07-01)
    Get full text
    Article


Search Tools: